Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis

References

• KanisJAWHO Technical Report66United KingdomUniversity of Sheffield2007
   Google Scholar
• GullbergBJohnellOKanisJAWorld-wide projections for hip fractureOsteoporos Int1997754074139425497
   PubMed Web of Science ®Google Scholar
• YangYWangBFeiQValidation of an osteoporosis self-assessment tool to identify primary osteoporosis and new osteoporotic vertebral fractures in postmenopausal Chinese women in BeijingBMC Musculoskelet Disord201314127127424053509
   PubMed Web of Science ®Google Scholar
• KatzSWeinermanSOsteporosis and gastrointestinal diseaseGastroenterol Hepatol (NY)20106506517
   PubMedGoogle Scholar
• KatzSOsteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatmentRev Gastroenterol Disord20066637116699475
   PubMedGoogle Scholar
• LarsenSBendtzenKNielsenOHExtraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and managementAnn Med20104229711420166813
   PubMed Web of Science ®Google Scholar
• LevineJSBurakoffRExtraintestinal manifestations of inflammatory bowel diseaseGastroenterol Hepatol (NY)20117235241
   PubMedGoogle Scholar
• UpalaSJaruvongvanichVWijarnpreechaKSanguankeoANonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysisJ Bone Miner Metab201735668569327928661
   PubMed Web of Science ®Google Scholar
• SassDAChangPChopraKBNonalcoholic fatty liver disease: a clinical reviewDig Dis Sci20055017118015712657
   PubMed Web of Science ®Google Scholar
• PoggiogalleEDoniniLMLenziAChiesaCPacificoLNonalcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscleWorld J Gastroenterol201723101747175728348479
   PubMed Web of Science ®Google Scholar
• ChalasaniNYounossiZLavineJEThe diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological AssociationAm J Gastroenterol2012107681182622641309
   PubMed Web of Science ®Google Scholar
• KirpichIAMarsanoLSMcclainCJGut–liver axis, nutrition, and non-alcoholic fatty liver diseaseClin Biochem20154813–1492393026151226
   PubMed Web of Science ®Google Scholar
• TeixeiraTFSColladoMCFerreiraCLLFBressanJPeluzio MdoCPotential mechanisms for the emerging link between obesity and increased intestinal permeabilityNutr Res201232963764723084636
   PubMed Web of Science ®Google Scholar
• TargherGLonardoARossiniMNonalcoholic fatty liver disease and decreased bone mineral density: is there a link?J Endocrinol Invest201538881782526003827
   PubMed Web of Science ®Google Scholar
• BertolottiMLonardoAMussiCNonalcoholic fatty liver disease and aging: Epidemiology to managementWorld J Gastroenterol20142039141851420425339806
   PubMed Web of Science ®Google Scholar
• XiaM-FLinH-DYanH-MThe association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal womenJ Transl Med20161411126791408
   PubMed Web of Science ®Google Scholar
• CuiRShengHRuiX-FLow bone mineral density in Chinese adults with nonalcoholic fatty liver diseaseInt J Endocrinol20132013139654539654623983685
   PubMed Web of Science ®Google Scholar
• LeeSHYunJMKimSHAssociation between bone mineral density and nonalcoholic fatty liver disease in Korean adultsJ Endocrinol Invest201639111329133627561910
   PubMed Web of Science ®Google Scholar
• BhattSPNigamPMisraAGuleriaRQadar PashaMAIndependent associations of low 25 hydroxy vitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in north IndiaAtherosclerosis2013230115716323958268
   PubMed Web of Science ®Google Scholar
• PacificoLBezziMLombardoCVAdipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver diseaseWorld J Gastroenterol201319254007401423840146
   PubMed Web of Science ®Google Scholar
• PardeePEDunnWSchwimmerJBNon-alcoholic fatty liver disease is associated with low bone mineral density in obese childrenAliment Pharmacol Ther201235224825422111971
   PubMed Web of Science ®Google Scholar
• ReidIRBollandMJGreyAEffects of vitamin D supplements on bone mineral density: a systematic review and meta-analysisLancet2014383991214615524119980
   PubMed Web of Science ®Google Scholar
• FrancisRMCalcium, vitamin D and involutional osteoporosisCurr Opin Clin Nutr Metab Care20069131716340655
   PubMed Web of Science ®Google Scholar
• LipsPBouillonRvan SchoorNMREVIEW ARTICLE: Reducing fracture risk with calcium and vitamin DClin Endocrinol2010733277285
   Web of Science ®Google Scholar
• LipsPVitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implicationsEndocr Rev200122447750111493580
   PubMed Web of Science ®Google Scholar
• WangXLiWZhangYYangYQinGAssociation between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysisInt J Clin Exp Med20158172211723426770315
   PubMed Web of Science ®Google Scholar
• EliadesMSpyrouEAgrawalNMeta-analysis: vitamin D and non-alcoholic fatty liver diseaseAliment Pharmacol Ther201338324625423786213
   PubMed Web of Science ®Google Scholar
• KwokRMTorresDMHarrisonSAVitamin D and nonalcoholic fatty liver disease (NAFLD): Is it more than just an association?Hepatology20135831166117423504808
   PubMed Web of Science ®Google Scholar
• BarchettaIdel BenMAngelicoFNo effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trialBMC Med20161419227353492
   PubMed Web of Science ®Google Scholar
• NakanoTChengY-FLaiC-YImpact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in ratsJ Hepatol201155241542521184788
   PubMed Web of Science ®Google Scholar
• AbramovitchSSharvitEWeismanYVitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosisAm J Physiol Gastrointest Liver Physiol20153082G112G12025214398
   PubMed Web of Science ®Google Scholar
• SuDNieYZhuAVitamin D signaling through induction of Paneth cell defensins maintains gut microbiota and improves metabolic disorders and hepatic steatosis in animal modelsFront Physiol201615498
   Google Scholar
• TakiishiTDingLBaekeFDietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in NOD mice when given early and long termDiabetes20146362026203624550187
   PubMed Web of Science ®Google Scholar
• TakayashiYThe role of growth hormone and insulin-like growth factor-I in the liverInt J Mol Sci2017181441
   Web of Science ®Google Scholar
• AguirreGAde ItaJRde La GarzaRGCastilla-CortazarIInsulin-like growth factor-1 deficiency and metabolic syndromeJ Transl Med2016141326733412
   PubMed Web of Science ®Google Scholar
• SumidaYYoneiYTanakaSLower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver diseaseHepatol Res201545777178125163357
   PubMed Web of Science ®Google Scholar
• VölzkeHNauckMRettigRAssociation between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sampleEur J Endocrinol2009161570571319690083
   PubMed Web of Science ®Google Scholar
• TakahashiYEssential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liverEndocr J2012591195596222986486
   PubMed Web of Science ®Google Scholar
• PerriniSLaviolaLCarreiraMCCignarelliANatalicchioAGiorginoFThe GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosisJ Endocrinol2010205320121020197302
   PubMed Web of Science ®Google Scholar
• BikleDDTahimicCChangWWangYPhilippouABartonERRole of IGF-I signaling in muscle bone interactionsBone201580798826453498
   PubMed Web of Science ®Google Scholar
• SugimotoTNishiyamaKKuribayashiFChiharaKSerum levels of IGF-I, IGFBP-2, and IGFBP-3 in osteoporotic patients with and without spine fracturesJ Bone Miner Res199712127212799258758
   PubMed Web of Science ®Google Scholar
• BauerDCRosenCCauleyJCummingsSRLow serum IGF-I but not IGFBP-3 predicts hip and spine fracture: the study of osteoporotic fractureJ Bone Miner Res199823S561
   Google Scholar
• DonahueLRRosenCJIGFs and bone. The osteoporosis connection revisitedProc Soc Exp Biol Med1998219179751217
   PubMed Web of Science ®Google Scholar
• Okman-KilicTSagirogluCAnabolic Agents as New Treatment Strategy in Osteoporosis, Topics in Osteoporosis2013 Available from: http://www.intechopen.com/embed/topics-in-osteoporosis/anabolic-agents-as-new-treatment-strategy-in-osteoporosisAccessed September 7, 2018
   Google Scholar
• GhironLThompsonJHallowayLButterfieldGEHoffmanAMarcusREffects of rhGH and IGF-I on bone turnover in elderly womenJ Bone Miner Res199510184418528619364
   PubMed Web of Science ®Google Scholar
• LiuJ-MinZhaoH-YanNingGIGF-1 as an early marker for low bone mass or osteoporosis in premenopausal and postmenopausal womenJ Bone Miner Metab200826215916418301972
   PubMed Web of Science ®Google Scholar
• OhlssonCBengtssonBAIsakssonOGPAndreassenTTSlootwegMGrowth hormone and boneEndocr Rev199819155799494780
   PubMed Web of Science ®Google Scholar
• RansjöMLernerUOhlssonCGrowth hormone inhibits formation of osteoclast like cells in mouse bone marrow culturesJ Bone Miner Res199611T394
   Web of Science ®Google Scholar
• KayaMIşıkDBeştaşRIncreased bone mineral density in patients with nonalcoholic steatohepatitisWorld J Hepatol201351162763424303091
   PubMedGoogle Scholar
• SekiESchwabeRFHepatic inflammation and fibrosis: Functional links and key pathwaysHepatology20156131066107925066777
   PubMed Web of Science ®Google Scholar
• JarrarMHBaranovaACollantesRAdipokines and cytokines in non-alcoholic fatty liver diseaseAliment Pharmacol Ther200827541242118081738
   PubMed Web of Science ®Google Scholar
• ChuCJRhLWangSSRisk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alphaHepatogastroenterology2007542099210218251167
   PubMedGoogle Scholar
• PoniachikJCsendesADíazJCIncreased production of IL-1α and TNF-α in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver diseaseCytokine200633525225716564703
   PubMed Web of Science ®Google Scholar
• SatapathySKGargSChauhanRBeneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitisAm J Gastroenterol200499101946195215447754
   PubMed Web of Science ®Google Scholar
• AbiruSMigitaKMaedaYSerum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitisLiver Int2006261394516420507
   PubMed Web of Science ®Google Scholar
• YilmazYReview article: non-alcoholic fatty liver disease and osteoporosis – clinical and molecular crosstalkAliment Pharmacol Ther201236434535222730920
   PubMed Web of Science ®Google Scholar
• OstaBBenedettiGMiossecPClassical and paradoxical effects of TNF-α on bone homeostasisFront Immunol201454824592264
   PubMed Web of Science ®Google Scholar
• WeitzmannMNBone and the immune systemToxicol Pathol201745791192429046115
   PubMed Web of Science ®Google Scholar
• IndridasonOSFranzsonLSigurdssonGSerum osteoprotegerin and its relationship with bone mineral density and markers of bone turnoverOsteoporos Int200516441742315776220
   PubMed Web of Science ®Google Scholar
• SzulcPHofbauerLCHeufelderAERothSDelmasPDOsteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone statusJ Clin Endocrinol Metab20018673162316511443182
   PubMed Web of Science ®Google Scholar
• Mezquita-RayaPde La HigueraMGarcíaDFThe contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal womenOsteoporos Int200516111368137415711777
   PubMed Web of Science ®Google Scholar
• KongY-YBoyleWJPenningerJMOsteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte developmentImmunol Cell Biol199977218819310234557
   PubMed Web of Science ®Google Scholar
• YilmazYYonalOKurtRSerum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver diseaseScand J Clin Lab Invest201070854154620942739
   PubMed Web of Science ®Google Scholar
• YangMLiuYZhouGValue of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitisZhonghua Gan Zang Bing Za Zhi2016249610126983475
   PubMedGoogle Scholar
• NiuYZhangWYangZPlasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case–control study in ChinaMetabolism201665447548126975539
   PubMed Web of Science ®Google Scholar
• StefanNHäringH-UThe role of hepatokines in metabolismNat Rev Endocrinol20139314415223337953
   PubMed Web of Science ®Google Scholar
• JhIShlipakMGBrandenburgVMAliSKettelerMWhooleyMAAssociation between human fetuin-A and the metabolic syndrome: data from the Heart and Soul StudyCirculation20061131760176716567568
   PubMed Web of Science ®Google Scholar
• XuYXuMBiYSerum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly ChineseAtherosclerosis2011216118018621310413
   PubMed Web of Science ®Google Scholar
• CuiZXuanRYangYSerum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese populationOncotarget201786310714910715629291018
   PubMedGoogle Scholar
• HaukelandJWDahlTBYndestadAFetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studiesEur J Endocrinol2012166350351022170794
   PubMed Web of Science ®Google Scholar
• SatoMKamadaYTakedaYFetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjectsLiver Int201535392593525627311
   PubMed Web of Science ®Google Scholar
• BrylkaLJahnen-DechentWThe role of fetuin-A in physiological and pathological mineralizationCalcif Tissue Int201393435536423277412
   PubMed Web of Science ®Google Scholar
• ChailurkitLKruavitARajatanavinROngphiphadhanakulBThe relationship of fetuin-A and lactoferrin with bone mass in elderly womenOsteoporos Int20112272159216420963400
   PubMed Web of Science ®Google Scholar
• ÖzkanEÖzkanHBilgiçSSerum fetuin-A levels in postmenopausal women with osteoporosisTurk J Med Sci20144498598825552151
   PubMed Web of Science ®Google Scholar
• GursoyGAcarYAlagozSOsteopontin: A multifunctional moleculeJ Med Sci201015560
   Google Scholar
• RittlingSRMatsumotoHNMckeeMDMice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitroJ Bone Miner Res1998137110111119661074
   PubMed Web of Science ®Google Scholar
• RezaSShaukatAMahmudMArainTRezaUWaheedFEvaluation of osteopontin in combination with bone turnover markers for the assessment of osteoporosis in postmenopausal womenBr J Med Med Res2016146111
   Google Scholar
• LundSAGiachelliCMScatenaMThe role of osteopontin in inflammatory processesJ Cell Commun Signal200933–431132219798593
   PubMed Web of Science ®Google Scholar
• ChapmanJMilesPDOfrecioJMOsteopontin is required for the early onset of high fat diet-induced insulin resistance in micePLoS One2010511e1395921103061
   PubMed Web of Science ®Google Scholar
• KieferFWNeschenSPfauBOsteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in miceDiabetologia20115482132214221562757
   PubMed Web of Science ®Google Scholar
• RosenCJBouxseinMLMechanisms of disease: is osteoporosis the obesity of bone?Nat Clin Pract Rheumatol200621354316932650
   PubMedGoogle Scholar
• OldbergAFranzenAHeinegardDCloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequenceProc Natl Acad Sci19868323881988233024151
   PubMed Web of Science ®Google Scholar
• NomiyamaTPerez-TilveDOgawaDOsteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in miceJ Clin Invest2007117102877288817823662
   PubMed Web of Science ®Google Scholar
• KwonH-JWonY-SYoonW-KNamK-HKimD-YKimH-CThe role of osteopontin in d-galactosamine-induced liver injury in genetically obese miceToxicol Appl Pharmacol2010242334435119913045
   PubMed Web of Science ®Google Scholar
• SahaiAMalladiPMelin-AldanaHGreenRMWhitingtonPFUpregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine modelAm J Physiol Gastrointest Liver Physiol20042871G264G27315044174
   PubMed Web of Science ®Google Scholar
• SahaiAMalladiPPanXObese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontinAm J Physiol Gastrointest Liver Physiol20042875G1035G104315256362
   PubMed Web of Science ®Google Scholar
• ChiangT-IChangI-CLeeH-SLeeHHuangC-HChengY-WOsteopontin regulates anabolic effect in human menopausal osteoporosis with intermittent parathyroid hormone treatmentOsteoporos Int201122257758520734029
   PubMed Web of Science ®Google Scholar
• FerronMMckeeMDLevineRLDucyPKarsentyGIntermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in miceBone201250256857521550430
   PubMed Web of Science ®Google Scholar
• DuJZhangMLuJOsteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNKEndocrine201653370170926994931
   PubMed Web of Science ®Google Scholar
• SaleemUMosleyTHKulloIJSerum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndromeArterioscler Thromb Vasc Biol20103071474147820395593
   PubMed Web of Science ®Google Scholar
• YeapBBChubbSAPFlickerLReduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levelsEur J Endocrinol2010163226527220501596
   PubMed Web of Science ®Google Scholar
• HwangY-CJeongI-KAhnK-JChungH-YCirculating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin levelOsteoporos Int20122341337134221656264
   PubMed Web of Science ®Google Scholar
• ZhouBLiHXuLZangWWuSSunHOsteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-κB signaling pathwayEndocrinology201315431055106823407450
   PubMed Web of Science ®Google Scholar
• YilmazYKurtRErenFImeryuzNSerum osteocalcin levels in patients with nonalcoholic fatty liver disease: Association with ballooning degenerationScand J Clin Lab Invest201171863163621859358
   PubMed Web of Science ®Google Scholar
• AminSEl AmrousyDElrifaeySGamalRHodeibHSerum osteocalcin levels in children with nonalcoholic fatty liver diseaseJ Pediatr Gastroenterol Nutr201866111712128991837
   PubMed Web of Science ®Google Scholar
• LuoY-QiMaX-JingHaoY-PingInverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levelsActa Pharmacol Sin201536121497150226567728
   PubMed Web of Science ®Google Scholar
• YangHJShimSGMaBOKwakJYAssociation of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean menEur J Gastroenterol Hepatol201628333834426636404
   PubMed Web of Science ®Google Scholar
• BoutariCPerakakisNMantzorosCSAssociation of adipokines with development and progression of nonalcoholic fatty liver diseaseEndocrinol Metab20183313343
   Web of Science ®Google Scholar
• EbiharaKKusakabeTHirataMEfficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophyJ Clin Endocrinol Metab200792253254117118991
   PubMed Web of Science ®Google Scholar
• XuAWangYKeshawHXuLYLamKSCooperGJThe fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in miceJ Clin Invest200311219110012840063
   PubMed Web of Science ®Google Scholar
• MirzaSQuHQLiQAdiponectin/leptin ratio and metabolic syndrome in a Mexican American populationClin Invest Med2011345290
   Web of Science ®Google Scholar
• SuhHSHwangICLeeKSKimKKRelationships between serum osteocalcin, leptin and the effect of weight loss by pharmacological treatment in healthy, nonsmoking Korean obese adultsClin Chim Acta2013418172123247052
   PubMed Web of Science ®Google Scholar
• OshimaKNampeiAMatsudaMAdiponectin increases bone mass by suppressing osteoclast and activating osteoblastBiochem Biophys Res Commun2005331252052615850790
   PubMed Web of Science ®Google Scholar
• KanazawaIYamaguchiTYanoSYamauchiMYamamotoMSugimotoTAdiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cellsBMC Cell Biol2007815118047638
   PubMedGoogle Scholar
• YadavVKOuryFSudaNA serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditureCell2009138597698919737523
   PubMed Web of Science ®Google Scholar
• ConfavreuxCBBone: from a reservoir of minerals to a regulator of energy metabolismKidney Int201179Suppl 121S14S19
   Web of Science ®Google Scholar
• MussoGPaschettaEGambinoRCassaderMMolinaroFInteractions among bone, liver, and adipose tissue predisposing to diabesity and fatty liverTrends Mol Med201319952253523816817
   PubMed Web of Science ®Google Scholar
• ZeadinMGButcherMKShaughnessySGWerstuckGHLeptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3βBiochem Biophys Res Commun2012425492493022906741
   PubMed Web of Science ®Google Scholar
• DemambroVEMaileLWaiCInsulin-like growth factor-binding protein-2 is required for osteoclast differentiationJ Bone Miner Res201227239040022006816
   PubMed Web of Science ®Google Scholar
• WilliamsGAWangYCallonKEIn vitro and in vivo effects of adiponectin on boneEndocrinology200915083603361019406946
   PubMed Web of Science ®Google Scholar
• BernerHSLyngstadaasSPSpahrAAdiponectin and its receptors are expressed in bone-forming cellsBone200435484284915454091
   PubMed Web of Science ®Google Scholar
• MitsuiYGotohMFukushimaNHyperadiponectinemia enhances bone formation in miceBMC Musculoskelet Disord2011121821241476
   PubMed Web of Science ®Google Scholar
• TuQZhangJDongLQAdiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1J Biol Chem201128614125421255321300805
   PubMed Web of Science ®Google Scholar
• WuNWangQPLiHWuXPSunZQLuoXHRelationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese womenClin Chim Acta20104119–1077177520184866
   PubMed Web of Science ®Google Scholar
• FuggleNRWestburyLDSyddallHERelationships between markers of inflammation and bone density: findings from the Hertfordshire Cohort StudyOsteoporos Int20182971581158929808230
   PubMed Web of Science ®Google Scholar
• TentaRKontogianniMDYiannakourisNAssociation between circulating levels of adiponectin and indices of bone mass and bone metabolism in middle-aged post-menopausal womenJ Endocrinol Invest201235330631121606670
   PubMed Web of Science ®Google Scholar
• ThrailkillKMLumpkinCKBunnRCKempSFFowlkesJLIs insulin an anabolic agent in bone? Dissecting the diabetic bone for cluesAm J Physiol Endocrinol Metab20052895E735E74516215165
   PubMed Web of Science ®Google Scholar
• LaurentMRCookMJGielenELower bone turnover and relative bone deficits in men with metabolic syndrome: a matter of insulin sensitivity? The European Male Ageing StudyOsteoporos Int201627113227323727273111
   PubMed Web of Science ®Google Scholar
• RiddleRCClemensTLInsulin, osteoblasts, and energy metabolism: why bone counts caloriesJ Clin Invest201412441465146724642463
   PubMed Web of Science ®Google Scholar
• WeiJFerronMClarkeCJBone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activationJ Clin Invest2014124417811793
   Web of Science ®Google Scholar
• SrikanthanPCrandallCJMiller-MartinezDInsulin resistance and bone strength: findings from the study of midlife in the United StatesJ Bone Miner Res201429479680323983216
   PubMed Web of Science ®Google Scholar
• XuJLombardiGJiaoWBanfiGEffects of exercise on bone status in female subjects, from young girls to postmenopausal women: an overview of systematic reviews and meta-analysesSports Med20164681165118226856338
   PubMed Web of Science ®Google Scholar
• JohnsonNAGeorgeJFitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver diseaseHepatology201052137038020578153
   PubMed Web of Science ®Google Scholar
• ZhangHJZhangXFMaZMIrisin is inversely associated with intrahepatic triglyceride contents in obese adultsJ Hepatol201359355756223665283
   PubMed Web of Science ®Google Scholar
• BerzigottiASaranUDufourJFPhysical activity and liver diseasesHepatology20166331026104026313307
   PubMed Web of Science ®Google Scholar
• Arias-LosteMTRanchalIRomero-GómezMCrespoJIrisinCJIrisin, a link among fatty liver disease, physical inactivity and insulin resistanceInt J Mol Sci20141512231632317825514415
   PubMed Web of Science ®Google Scholar
• di IorgiNMittelmanSDGilsanzVDifferential effect of marrow adiposity and visceral and subcutaneous fat on cardiovascular risk in young, healthy adultsInt J Obes2008321218541860
   Web of Science ®Google Scholar
• BaumTYapSPKarampinosDCDoes vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus?J Magn Reson Imaging201235111712422190287
   PubMed Web of Science ®Google Scholar
• SchellerELRosenCJWhat’s the matter with MAT? Marrow adipose tissue, metabolism, and skeletal healthAnn N Y Acad Sci20141311143024650218
   PubMed Web of Science ®Google Scholar
• FazeliPKHorowitzMCMacdougaldOAMarrow fat and bone – new perspectivesJ Clin Endocrinol Metab201398393594523393168
   PubMed Web of Science ®Google Scholar
• LinHGrosschedlRFailure of B-cell differentiation in mice lacking the transcription factor EBFNature199537665372632677542362
   PubMed Web of Science ®Google Scholar
• PongubalaJMNorthrupDLLanckiDWTranscription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5Nat Immunol20089220321518176567
   PubMed Web of Science ®Google Scholar
• HessleinDGFretzJAXiYEbf1-dependent control of the osteoblast and adipocyte lineagesBone200944453754619130908
   PubMed Web of Science ®Google Scholar
• FazeliPKBredellaMAMisraMPreadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosaJ Clin Endocrinol Metab201095140741319850693
   PubMed Web of Science ®Google Scholar
• Kuro-OMKlotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolismCurr Opin Nephrol Hypertens200615443744116775459
   PubMed Web of Science ®Google Scholar
• HsiehCCKuro-OMRosenblattKPBrobeyRPapaconstantinouJThe ASK1-Signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of agingAging20102959761120844314
   PubMedGoogle Scholar
• Ben-DovIZGalitzerHLavi-MoshayoffVThe parathyroid is a target organ for FGF23 in ratsJ Clin Invest2007117124003400817992255
   PubMed Web of Science ®Google Scholar
• SommEHenryHBruceSJβ-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissueJCI Insight201728e91809
   Web of Science ®Google Scholar
• KurosuHKuro-OMThe Klotho gene family as a regulator of endocrine fibroblast growth factorsMol Cell Endocrinol20092991727819063940
   PubMed Web of Science ®Google Scholar
• DominguezLJBarbagalloMThe biology of the metabolic syndrome and agingCurr Opin Clin Nutr Metab Care201619151126560521
   PubMed Web of Science ®Google Scholar
• HsuYHVennersSATerwedowHARelation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and womenAm J Clin Nutr200683114615416400063
   PubMed Web of Science ®Google Scholar
• HwangDKChoiHJThe relationship between low bone mass and metabolic syndrome in Korean womenOsteoporos Int201021342543119565174
   PubMed Web of Science ®Google Scholar
• MadanKBhardwajPTharejaSGuptaSDSarayaAOxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)J Clin Gastroenterol2006401093093517063114
   PubMed Web of Science ®Google Scholar
• LiMXuYXuMAssociation between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly ChineseJ Clin Endocrinol Metab20129762033203822466338
   PubMed Web of Science ®Google Scholar
• CollierJBone disorders in chronic liver diseaseHepatology20074641271127817886334
   PubMed Web of Science ®Google Scholar
• Solaymani-DodaranMCardTRAithalGPWestJFracture risk in people with primary biliary cirrhosis: a population-based cohort studyGastroenterology200613161752175717087953
   PubMed Web of Science ®Google Scholar
• MenonKVAnguloPWestonSDicksonERLindorKDBone disease in primary biliary cirrhosis: independent indicators and rate of progressionJ Hepatol200135331632311592591
   PubMed Web of Science ®Google Scholar
• WangDLiuNGaoYLiPTianMAssociation between metabolic syndrome and osteoporotic fracture in middle-aged and elderly Chinese peoplesCell Biochem Biophys20147021297130324908263
   PubMed Web of Science ®Google Scholar
• QinLYangZZhangWMetabolic syndrome and osteoporotic fracture: a population-based study in ChinaBMC Endocr Disord2016161273027233999
   PubMed Web of Science ®Google Scholar